These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 10093661)
1. [From Thibierge-Weissenbach syndrome (1910) to anti-centromere antibodies (1980). Clinical and biological features of scleroderma]. Meyer O Ann Med Interne (Paris); 1999 Jan; 150(1):47-52. PubMed ID: 10093661 [TBL] [Abstract][Full Text] [Related]
2. Clinical and serological heterogeneity in patients with anticentromere antibodies. Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324 [TBL] [Abstract][Full Text] [Related]
3. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance]. Meurer M; Scharf A; Luderschmidt C; Braun-Falco O Dtsch Med Wochenschr; 1985 Jan; 110(1):8-14. PubMed ID: 3880700 [TBL] [Abstract][Full Text] [Related]
4. [Anti-Scl-70 antibodies in systemic scleroderma]. Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650 [TBL] [Abstract][Full Text] [Related]
5. [CREST syndrome]. Meyer O Ann Med Interne (Paris); 2002 May; 153(3):183-8. PubMed ID: 12218901 [TBL] [Abstract][Full Text] [Related]
6. [The clinical spectrum of patients with anticentromere antibodies]. Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719 [TBL] [Abstract][Full Text] [Related]
8. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. Giordano M; Valentini G; Migliaresi S; Picillo U; Vatti M J Rheumatol; 1986 Oct; 13(5):911-6. PubMed ID: 3546686 [TBL] [Abstract][Full Text] [Related]
9. Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases. Ruffatti A; Calligaro A; Ferri C; Bombardieri S; Gambari PF; Todesco S J Clin Lab Immunol; 1985 Apr; 16(4):227-9. PubMed ID: 3874966 [TBL] [Abstract][Full Text] [Related]
10. [Significance of anti-centromere antibodies. Clinical value]. Meyer O; Haim T; Ryckewaert A Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931 [TBL] [Abstract][Full Text] [Related]
15. Anti-centromere autoantibody in a patient evolving from a lupus/Sjögren's overlap to the CREST variant of scleroderma. Ford AL; Kurien BT; Harley JB; Scofield RH J Rheumatol; 1998 Jul; 25(7):1419-24. PubMed ID: 9676778 [TBL] [Abstract][Full Text] [Related]
16. Drug-induced anticentromere antibody? Haberhauer G; Bröll H Z Rheumatol; 1989; 48(2):99-100. PubMed ID: 2786663 [TBL] [Abstract][Full Text] [Related]
17. Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma. Tubach F; Hayem G; Elias A; Nicaise P; Haim T; Kahn MF; Meyer O Rev Rhum Engl Ed; 1997 Jun; 64(6):362-7. PubMed ID: 9513607 [TBL] [Abstract][Full Text] [Related]
18. [Anti-centromere antibodies. Study of 67 positive sera]. Renier G; Le Normand I; Chevailler A; Verret JL; Renier JC; Hurez D Rev Med Interne; 1992 Nov; 13(6):413-4, 417-8. PubMed ID: 1344922 [TBL] [Abstract][Full Text] [Related]